Search

everythinglearnresearchcommunity

for

Search:↓

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Vitamin D receptor helps prevent skin tumors.

Hair samples can reliably monitor tacrolimus levels in kidney transplant patients.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Thyroid receptor β can help develop new drugs to treat hair loss.

The botanical treatment for hair loss shows promise, especially for children.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Topical tacrolimus did not regrow hair in alopecia universalis patients.

Vitamin D receptor helps prevent skin tumors.

Sorafenib can cause a unique skin reaction.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

A specific gene mutation causes vitamin D resistance, but certain vitamin D analogs might help.

Ozonated olive oil may effectively treat fungal skin infections.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Tridax procumbens is a plant with many health benefits, including healing, protecting the liver, fighting infections, and promoting hair growth.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Nocturnal calcium infusions improved a boy's severe rickets without causing hair loss.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Topical tacrolimus reduces certain growth factors in hair follicles.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.